Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Hashimoto

Showing results (141-150 of 271) with videos related to

Pageof 28
Sort By:
Masui. the Japanese Journal of Anesthesiology|May 19, 2016
[Anesthetic Management of an Adrenoleukodystrophy Patient for Intrathecal Baclofen Therapy]Yuichi Hashimoto, Kei Takahashi, Yuko Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2015
Design and synthesis of silicon-containing fatty acid amide derivatives as novel peroxisome proliferator-activated receptor (PPAR) agonistsDaisuke Kajita, Masaharu Nakamura, Yotaro Matsumoto, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
Angiogenesis inhibitors derived from thalidomideTomomi Noguchi, Haruka Fujimoto, Hiroko Sano, et al.
Bioorganic & Medicinal Chemistry|April 26, 2011
Development of target protein-selective degradation inducer for protein knockdownYukihiro Itoh, Minoru Ishikawa, Risa Kitaguchi, et al.
Bioorganic & Medicinal Chemistry|June 8, 2014
Structure-activity relationship study of non-steroidal NPC1L1 ligands identified through cell-based assay using pharmacological chaperone effect as a readoutFumika Karaki, Kenji Ohgane, Hiromitsu Fukuda, et al.
Chemical & Pharmaceutical Bulletin|June 29, 2025
Photo-Enhanced Aqueous Solubilization of Azobenzene-Incorporated LipidsShusuke Tomoshige, Yushi Kawasaki, Junki Morimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Neurotoxic mechanisms by Alzheimer's disease-linked N141I mutant presenilin 2Yuichi Hashimoto, Takako Niikura, Yuko Ito, et al.
Bioorganic & Medicinal Chemistry|November 27, 2019
Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteinsHiroko Yamashita, Shusuke Tomoshige, Sayaka Nomura, et al.
Journal of Neuroscience Research|August 21, 2003
Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cellsEmi Tsukamoto, Yuichi Hashimoto, Kohsuke Kanekura, et al.
Journal of Medicinal Chemistry|July 26, 2002
Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actionsBitoku Takahashi, Kiminori Ohta, Emiko Kawachi, et al.
Pageof 28

Showing results (141-150 of 271) with videos related to

Sort By:
Pageof 28
Masui. the Japanese Journal of Anesthesiology|May 19, 2016
[Anesthetic Management of an Adrenoleukodystrophy Patient for Intrathecal Baclofen Therapy]Yuichi Hashimoto, Kei Takahashi, Yuko Yamamoto, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2015
Design and synthesis of silicon-containing fatty acid amide derivatives as novel peroxisome proliferator-activated receptor (PPAR) agonistsDaisuke Kajita, Masaharu Nakamura, Yotaro Matsumoto, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
Angiogenesis inhibitors derived from thalidomideTomomi Noguchi, Haruka Fujimoto, Hiroko Sano, et al.
Bioorganic & Medicinal Chemistry|April 26, 2011
Development of target protein-selective degradation inducer for protein knockdownYukihiro Itoh, Minoru Ishikawa, Risa Kitaguchi, et al.
Bioorganic & Medicinal Chemistry|June 8, 2014
Structure-activity relationship study of non-steroidal NPC1L1 ligands identified through cell-based assay using pharmacological chaperone effect as a readoutFumika Karaki, Kenji Ohgane, Hiromitsu Fukuda, et al.
Chemical & Pharmaceutical Bulletin|June 29, 2025
Photo-Enhanced Aqueous Solubilization of Azobenzene-Incorporated LipidsShusuke Tomoshige, Yushi Kawasaki, Junki Morimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Neurotoxic mechanisms by Alzheimer's disease-linked N141I mutant presenilin 2Yuichi Hashimoto, Takako Niikura, Yuko Ito, et al.
Bioorganic & Medicinal Chemistry|November 27, 2019
Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteinsHiroko Yamashita, Shusuke Tomoshige, Sayaka Nomura, et al.
Journal of Neuroscience Research|August 21, 2003
Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cellsEmi Tsukamoto, Yuichi Hashimoto, Kohsuke Kanekura, et al.
Journal of Medicinal Chemistry|July 26, 2002
Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actionsBitoku Takahashi, Kiminori Ohta, Emiko Kawachi, et al.
Pageof 28